Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) Income towards Parent Company: 2010-2025

Historic Income towards Parent Company for Corcept Therapeutics (CORT) over the last 11 years, with Sep 2025 value amounting to $19.7 million.

  • Corcept Therapeutics' Income towards Parent Company fell 58.34% to $19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.2 million, marking a year-over-year decrease of 25.15%. This contributed to the annual value of $141.2 million for FY2024, which is 33.04% up from last year.
  • Latest data reveals that Corcept Therapeutics reported Income towards Parent Company of $19.7 million as of Q3 2025, which was down 44.11% from $35.2 million recorded in Q2 2025.
  • In the past 5 years, Corcept Therapeutics' Income towards Parent Company registered a high of $47.2 million during Q3 2024, and its lowest value of $15.8 million during Q1 2023.
  • Moreover, its 3-year median value for Income towards Parent Company was $30.8 million (2024), whereas its average is $29.3 million.
  • In the last 5 years, Corcept Therapeutics' Income towards Parent Company soared by 89.07% in 2023 and then tumbled by 58.34% in 2025.
  • Over the past 5 years, Corcept Therapeutics' Income towards Parent Company (Quarterly) stood at $32.1 million in 2021, then slumped by 48.20% to $16.6 million in 2022, then skyrocketed by 89.07% to $31.4 million in 2023, then fell by 1.96% to $30.8 million in 2024, then tumbled by 58.34% to $19.7 million in 2025.
  • Its Income towards Parent Company stands at $19.7 million for Q3 2025, versus $35.2 million for Q2 2025 and $20.5 million for Q1 2025.